SeaStar Medical Holding Corp (ICU)
4.28
+0.22
(+5.42%)
USD |
NASDAQ |
Sep 27, 16:00
4.24
-0.04
(-0.93%)
After-Hours: 20:00
SeaStar Medical SG&A Expense (Annual): 8.237M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.237M |
| December 31, 2022 | 6.916M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.683M |
| December 31, 2020 | 2.428M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.683M
Minimum
2021
8.237M
Maximum
2023
4.816M
Average
4.672M
Median
SG&A Expense (Annual) Benchmarks
| Bolt Biotherapeutics Inc | 22.53M |
| CVS Health Corp | -- |
| Walgreens Boots Alliance Inc | 34.20B |
| Nuwellis Inc | 17.19M |
| Verastem Inc | 30.73M |